Truist raised the firm’s price target on Leidos (LDOS) to $220 from $195 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in Government Services names. The firm is cautious on the sector heading into earnings due to potential near-term risk estimates for Middle East exposure and sub-par book-to-bill from the war, though it also believes that investors should focus on companies with Defense/Admin priority alignment, the analyst tells investors in a research note. The stock is among the FedCiv-exposed names that could see multiple expansion if Democrats win in the midterms, Truist added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LDOS:
- Leidos: Joint Venture With Analogic Unlocks Long-Term Value Creation and Supports Buy Rating
- Leidos Forms Joint Venture with Altaris and Analogic
- Leidos’ SES unit and Analogic to combine under Analogic leadership
- Leidos, Altaris enter joint venture agreement
- Leidos price target lowered to $185 from $215 at Jefferies
